Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimally Invasive Esophagectomy Improves Survival

By HospiMedica staff writers
Posted on 13 May 2003
The results of the largest study to date evaluating minimally invasive esophagectomy (MIE) to treat esophageal cancer show that the procedure reduces mortality rates and hospital stays compared to most open procedures. More...
These results were reported at the annual meeting of the American Surgical Association in Washington, DC (USA).

Researchers evaluated MIE in 221 patients, comparing hospital stays and mortality rates with similarly sized studies of open methods, including thoracotomy and laparotomy, or both. The results showed that the median hospital stay was seven days for patients with MIE, compared to more than 10 days for patients with open procedures. Also, mortality occurred in 1.3% of the MIE patients, compared to rates of up to 5% or higher reported for open procedures.

MIE is a video-assisted surgical procedure that utilizes instruments introduced into the body through very small incisions and a laparoscope. Patients who are candidates for MIE undergo extensive preoperative evaluation involving laparoscopic staging, endoscopic ultrasound, and computed tomography (CT) scans to assess the extent of the disease.
"Our study demonstrates that minimally invasive esophagectomy offers results as good as, if not better than, open esophageal procedures,” said Dr. James D. Luketich, associate professor of surgery, University of Pittsburgh Medical Center (PA, USA). However, Dr. Luketich stressed that the success of esophagectomy, regardless of method used, largely depends on surgical expertise in the procedure and a high volume of procedures performed annually.





Related Links:
U. of Pittsburgh

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.